Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.410.370.350.370.31

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.41 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.41
Mar20240.37
Mar20230.35
Mar20220.37
Mar20210.31

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.41
10.81
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37
19.35
Mar2021 0.31 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,682.9 Cr 4.3% -5.7% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,677.0 Cr -2.4% 6.4% 7% Stock Analytics
DIVIS LABORATORIES ₹180,458.0 Cr -0.9% 5% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹153,685.0 Cr 1.6% 7.6% 38.5% Stock Analytics
CIPLA ₹114,562.0 Cr 1.2% 7.7% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,095.0 Cr 0.1% -1.2% 8.7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

4.3%

-5.7%

-15.3%

SENSEX

0.7%

-1%

-7%


You may also like the below Video Courses